- Home
- OGE vs KYMR Comparison
OGE vs KYMR Comparison
Compare OGE & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OGE | KYMR |
|---|---|---|
| Founded | 1902 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Medicinal Chemicals and Botanical Products |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.8B | 9.6B |
| IPO Year | 2009 | 2020 |
Fundamental Metrics
Financial Performance| Metric | OGE | KYMR |
|---|---|---|
| Price | $49.94 | $110.28 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 26 |
| Target Price | $48.78 | ★ $107.72 |
| AVG Volume (30 Days) | ★ 1.3M | 920.7K |
| Earning Date | 04-29-2026 | 04-30-2026 |
| Dividend Yield | ★ 3.59% | N/A |
| EPS Growth | ★ 5.94 | N/A |
| EPS | ★ 0.24 | N/A |
| Revenue | ★ $3,260,100,000.00 | $39,211,000.00 |
| Revenue This Year | $3.74 | $10.61 |
| Revenue Next Year | $1.42 | $8.17 |
| P/E Ratio | $206.71 | ★ N/A |
| Revenue Growth | ★ 9.21 | N/A |
| 52 Week Low | $41.70 | $36.88 |
| 52 Week High | $50.26 | $130.05 |
Technical Indicators
Market Signals| Indicator | OGE | KYMR |
|---|---|---|
| Relative Strength Index (RSI) | 59.54 | 54.52 |
| Support Level | $46.21 | $108.87 |
| Resistance Level | $50.13 | $120.90 |
| Average True Range (ATR) | 0.83 | 5.47 |
| MACD | 0.05 | -1.68 |
| Stochastic Oscillator | 84.52 | 22.52 |
Price Performance
Historical ComparisonAbout OGE OGE Energy Corp
OGE Energy is a holding company for Oklahoma Gas & Electric, a regulated utility with electricity generation, transmission, and distribution service for 900,000 customers in Oklahoma and western Arkansas. In December 2021, OGE divested its 25.5% stake in Enable Midstream Partners, an oil and gas services company it created in 2013 through a unit exchange merger with Energy Transfer. OGE sold its 95.4 million limited partner units of Energy Transfer throughout 2022. OGE sold its retail gas business in 1928 and no longer has any gas operations.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.